Project Grant K23AG084883
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $114,498.00 to Temple University to investigate the construct validity of smartwatch-derived digital phenotypes against conventional neuropsychological measures and questionnaires for early detection of Alzheimer's disease and related dementias. The study will recruit a diverse sample of 90 participants aged 55 and older with either healthy cognition or mild cognitive impairment from the...
- This Project Grant award of $129,330 from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), supports research at the Massachusetts General Hospital (MGH) to address the critical unmet need for early and accurate detection of Alzheimer's disease and related dementias (ADRD). The key products and services to be delivered under this award include: 1) deploying a multi-modal information framework that leverages decades-long in vivo and digital...
- This Project Grant award of $199,830 from the National Institute on Aging (under CFDA 93.866 - Aging Research) aims to support Dr. Rowan Saloner in acquiring expertise to become a leading clinical researcher focused on unraveling the neurobiological underpinnings of clinical progression in frontotemporal lobar degeneration (FTLD), Alzheimer's disease (AD), and other related dementias (ADRD). The project will utilize large-scale proteomics, clinical characterization, and bioinformatics to...
- This Project Grant award of $353,391.00, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to validate the use of a "Personal Learning Curve" paradigm as a sensitive marker of early memory decline related to Alzheimer's disease (AD) biomarkers in a large, diverse sample of older adults. The study seeks to determine if this digital cognitive assessment tool, which measures learning over repeated evaluations, can detect subtle AD-related memory failures...
- This Project Grant award of $336,000.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to evaluate the utility of self-reported subjective cognitive concerns (SCC) as an early screening tool for Alzheimer's disease (AD). The project will: 1) assess the longitudinal relationship between baseline conventional pen-and-paper measures of SCC and subsequent plasma AD biomarkers, 2) examine whether baseline smartphone-based ecological momentary assessment (EMA) SCC measures...
- This National Institute on Aging (NIA) Project Grant award under the Aging Research Federal Grant Program (CFDA 93.866) aims to equip the candidate with the skills to establish an independent research program identifying modifiable lifestyle factors to enhance cognitive resilience in aging and Alzheimer's disease-related dementias (ADRDs). The 5-year, $129,659 award will support a longitudinal study to assess 1) whether physical activity and sleep are factors associated with cognitive resilience...
- This Project Grant award of $4,787,820.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to gain a better understanding of the individual- and system-level characteristics that influence diagnosis of mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD), and how diagnosis can moderate the effects of cognitive decline on employment, future care, and quality of life. The key objectives are to: 1) examine whether older adults experiencing...
- This Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) provides $441,612 to support research on the relationship between modifiable risk factors for Alzheimer's disease (AD) and digital cognitive measures as early indicators of cognitive decline. The project, led by Trustees of Boston University's Boston University Medical Campus, will utilize data from the Framingham Heart Study cohort to evaluate how lifestyle factors quantified by...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $885,006 to Brigham & Women's Hospital Inc. to develop a smartphone-based point-of-care diagnostic system for detecting Alzheimer's disease-related biomarkers in blood plasma. The system will utilize microfluidics, nanotechnology, optical sensing, and deep learning to measure amyloid-beta, phosphorylated tau, and neurofilament light chain within 30 minutes, with the goal of creating an...
- This $127,785 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will provide a PhD student at Stanford University the training necessary to launch an independent research career in computational epidemiology focused on neurological disorders. The key objectives of the project are to: (1) develop expertise in constructing mobile digital tools to...
PASSIVE DIGITAL PHENOTYPING FOR CAPTURING REAL-WORLD NEUROBEHAVIOR IN NEURODEGENERATIVE DISEASE - PROJECT SUMMARY/ABSTRACT THE OBJECTIVE OF THIS K23 CAREER DEVELOPMENT AWARD IS TO SUPPORT DR. EMILY PAOLILLO IN ACQUIRING THE EXPERTISE TO BECOME AN INDEPENDENT CLINICAL RESEARCHER FOCUSED ON USING PASSIVE DIGITAL HEALTH METHODOLOGIES AND MACHINE LEARNING ANALYTICS TO IMPROVE DETECTION AND MONITORING OF NEUROBEHAVIORAL CHANGE IN ALZHEIMER'S DISEASE AND RELATED DEMENTIAS (ADRD). THROUGH THE SUPPORT OF THIS K23 AND THE ENRICHED MULTIDISCIPLINARY TRAINING ENVIRONMENT AT THE UCSF MEMORY AND AGING CENTER, DR. PAOLILLO AIMS TO ACCOMPLISH TARGETED GOALS WITHIN THE FOLLOWING TRAINING DOMAINS: 1) PASSIVE DIGITAL PHENOTYPING IN ADRD; 2) BIG DATA/ MACHINE LEARNING ANALYTICS; AND 3) SCIENTIFIC LEADERSHIP. DR. PAOLILLO WILL TRANSLATE THE KNOWLEDGE, SKILLS, AND FINDINGS FROM THIS K23 INTO AN R01 TO INTEGRATE MULTIMODAL DIGITAL HEALTH TOOLS FOR COMPREHENSIVE, PERSON-SPECIFIC ASSESSMENT OF REALWORLD NEUROBEHAVIORAL CHANGE. TO ACHIEVE THESE GOALS, DR. PAOLILLO HAS ASSEMBLED AN ACCOMPLISHED MENTORSHIP TEAM WITH SPECIFIC PROJECT-RELEVANT EXPERTISE, INCLUDING: BIOBEHAVIORAL CORRELATES OF DEMENTIA PREVENTION AND WEARABLE ACTIGRAPHY (PRIMARY MENTOR DR. KAITLIN CASALETTO ); NEUROBEHAVIORAL PHENOTYPING OF AGE-RELATED COGNITIVE DECLINE (CO-PRIMARY MENTOR DR. JOEL KRAMER); SMARTPHONE-BASED COGNITIVE ASSESSMENT (CO-MENTOR DR. ADAM STAFFARONI); IN-HOME PASSIVE SENSOR TECHNOLOGY (CO-MENTOR DR. JEFFREY KAYE); MACHINE LEARNING AND HEALTH DATA SCIENCE (CO-MENTOR DR. STATHIS GENNATAS); LONGITUDINAL DATA ANALYSIS IN DEMENTIA (COMENTOR DR. JOHN KARNAK) AND NEUROBEHAVIORAL ASSESSMENT OF FRONTOTEMPORAL DEMENTIA (SCIENTIFIC ADVISOR DR. HOWARD ROSEN). THE OVERARCHING GOAL OF THE PROPOSED STUDY IS TO EXAMINE THE UTILITY OF A CUTTING-EDGE DIGITAL HEALTH APPROACH, NAMELY PASSIVE SMARTPHONE MONITORING, TO DETECT NEUROBEHAVIORAL IMPAIRMENT IN NEURODEGENERATIVE DISEASE. SMARTPHONE-BASED DIGITAL ASSESSMENT TOOLS HAVE POTENTIAL TO OVERCOME ACCESSIBILITY LIMITATIONS OF TRADITIONAL IN-PERSON NEUROPSYCHOLOGICAL EVALUATIONS, AS THEY ARE REMOTE AND UTILIZE UBIQUITOUS MOBILE TECHNOLOGY. EXAMINING DIGITAL ASSESSMENT METHODS STRONGLY ALIGNS WITH ACTIONS 2.B.1 ("IDENTIFY AND DISSEMINATE APPROPRIATE ASSESSMENT TOOLS") AND 2.B.2 ("SUPPORT TECHNOLOGY TO ADVANCE MOBILE MONITORING OF COGNITIVE CHANGES") OF THE 2022 NATIONAL PLAN TO ADDRESS ALZHEIMER'S DISEASE. PASSIVELY COLLECTED DIGITAL METRICS BASED ON NATURALISTIC SMARTPHONE INTERACTIONS REPRESENT A FEASIBLE, ACCESSIBLE, LOWBURDEN TOOL FOR REMOTE MONITORING AND EARLY DETECTION OF NEUROBEHAVIORAL CHANGE. THE AIMS OF THE PROPOSED STUDY ARE TO DETERMINE THE UTILITY OF PASSIVE SMARTPHONE METRICS TO MEASURE AND MONITOR CLINICAL OUTCOMES IN FRONTOTEMPORAL DEMENTIA (FTD) AND ALZHEIMER'S DISEASE (AD) BY TESTING ASSOCIATIONS WITH GOLD-STANDARD MEASURES OF COGNITION, NEURODEGENERATION, AND FUNCTIONAL IMPAIRMENT CROSS-SECTIONALLY AND LONGITUDINALLY. THIS STUDY WILL BE AMONG THE FIRST TO EXAMINE PASSIVE SMARTPHONE MONITORING IN FTD AND AD, WHICH IF SUCCESSFUL, WOULD CONTRIBUTE TO A LOW-BURDEN, HIGHLY SCALABLE, CONTINUOUS MONITORING TECHNIQUE FOR TIMELY DETECTION AND LONGITUDINAL MEASUREMENT OF NEUROBEHAVIORAL CHANGES WITH POTENTIAL TO IMPROVE ACCESS TO DEMENTIA CARE.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $197.5k | 8/11/25 | ||
| Not listed | $197.6k | 9/11/24 |